Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP588377.RASfhLI7LxGDmrCVp1XgEED5XULsLIHsLwWJOA4ry693k130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588377.RASfhLI7LxGDmrCVp1XgEED5XULsLIHsLwWJOA4ry693k130_provenance.
• NP875029.RAW4etyoSYk0_smuY-ZwcXtyFJ3HPbeoa5_yXls_rApN0130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875029.RAW4etyoSYk0_smuY-ZwcXtyFJ3HPbeoa5_yXls_rApN0130_provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1092321.RARUsz2-bBhoFfX9m01Wt485ETGtNmW8BRCN4Tx5SfjCY130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092321.RARUsz2-bBhoFfX9m01Wt485ETGtNmW8BRCN4Tx5SfjCY130_provenance.
• NP588058.RAu461l_Uw7IsO6GCX02DuFtspJ_atkKUw-HQwjBVrKlE130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588058.RAu461l_Uw7IsO6GCX02DuFtspJ_atkKUw-HQwjBVrKlE130_provenance.
• NP875028.RAqdafFhBvqrG52fbmU-XgVrqho4jtD4X77H7RWusT6MY130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875028.RAqdafFhBvqrG52fbmU-XgVrqho4jtD4X77H7RWusT6MY130_provenance.
• NP875053.RAtwHaQyOsv72qyNqG-QpoJWAPrfMhgKNqOQjsie7lwbM130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875053.RAtwHaQyOsv72qyNqG-QpoJWAPrfMhgKNqOQjsie7lwbM130_provenance.
• NP1092319.RAoVCorKGLMeCnzbtFUHgUWSYqJ49wqqeXv2ooMJ-imR4130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092319.RAoVCorKGLMeCnzbtFUHgUWSYqJ49wqqeXv2ooMJ-imR4130_provenance.
• NP1092324.RAgTICqiCSjao54xjIhkGG0NgLJn-AuJ6uYriPtxWCu_o130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092324.RAgTICqiCSjao54xjIhkGG0NgLJn-AuJ6uYriPtxWCu_o130_provenance.
• NP588075.RA_G0plAwSLdYaFkxtSNvhngGTr5CC_G2xRUg4o7SY7b8130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588075.RA_G0plAwSLdYaFkxtSNvhngGTr5CC_G2xRUg4o7SY7b8130_provenance.
• NP1092320.RAOT3iv0ZEN0tdHl1DmUQyVMRHaz-kNEHJGCpie7KRC1c130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092320.RAOT3iv0ZEN0tdHl1DmUQyVMRHaz-kNEHJGCpie7KRC1c130_provenance.
• NP1092322.RAFD8Mjd5z9xGYx1bxur6jZsYpBn2rHG2IXTm6AzzDYX4130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092322.RAFD8Mjd5z9xGYx1bxur6jZsYpBn2rHG2IXTm6AzzDYX4130_provenance.
• NP1092323.RA1LoMIH_PboEZKv_nmUTCrcA8RpNxauAewD0nbqCXFQo130_assertion description "[We also show that VAAST 2.0 outperforms KBAC, WSS, SKAT, and variable threshold (VT) using published case-control datasets for Crohn disease (NOD2), hypertriglyceridemia (LPL), and breast cancer (CHEK2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092323.RA1LoMIH_PboEZKv_nmUTCrcA8RpNxauAewD0nbqCXFQo130_provenance.